Skip to main content

Advertisement

Table 1 Clinical characteristics in patients with and without concomitant T2DM

From: Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study

Characteristic T2DM n = 50 No diabetes n = 80 p value
Age (years) 70 ± 9 70 ± 11 n.s.
Men/Women, n (%) 23/27 (46/54%) 44/36 (55/45%) n.s.
Symptoms, n (%)a 31 (62%) 41 (51%) n.s.
Hypertension, n (%) 45 (90%) 62 (78%) n.s.
Chronic kidney disease, n (%) 16 (32%) 17 (21%) n.s.
Body-mass index (kg/m2) 31 ± 5 28 ± 4 0.003
Mean blood pressure (mm Hg) 90 ± 10 89 ± 10 n.s.
Systolic blood pressure (mm Hg) 131 ± 16 130 ± 18 n.s.
Glycated hemoglobin (%) 7.1 ± 0.8
Medications, n (%)
 ACEI or ARB 30 (60%) 43 (54%) n.s.
 Beta-blocker 25 (50%) 34 (43%) n.s.
 Diuretic 20 (40%) 27 (34%) n.s.
 Calcium channel blockers 17 (34%) 24 (30%) n.s.
 Statin 38 (76%) 50 (62%) n.s.
 Metformin 47 (94%)
 Insulin 16 (32%)
  1. Data are shown as mean ± SD or n (%)
  2. ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers
  3. aA history of heart failure, syncope or angina linked to AS